The Isiah Factor Uncensored

Name: New FDA-Approved Pill Potentially Doubles Pancreatic Cancer Survival Time
Uploaded: 2026-08-28T05:03:44.000Z
Description: The FDA has officially approved Rasonque, a groundbreaking new daily pill that targets a specific genetic mutation to treat deadly pancreatic cancer. Medical experts say this massive breakthrough provides new hope for patients, with clinical trials showing the drug can double the average survival time.

New FDA-Approved Pill Potentially Doubles Pancreatic Cancer Survival Time

Published Friday, Aug. 28

The FDA has officially approved Rasonque, a groundbreaking new daily pill that targets a specific genetic mutation to treat deadly pancreatic cancer. Medical experts say this massive breakthrough provides new hope for patients, with clinical trials showing the drug can double the average survival time.